Skip to content
  • Sunday, 26 July 2026
  • 1:47 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • A Groundbreaking Viral ORFeome Platform Revolutionizes Human Disease Research and Pandemic Preparedness
Biotech & Genetic Research

A Groundbreaking Viral ORFeome Platform Revolutionizes Human Disease Research and Pandemic Preparedness

Jia Lissa Jul 15, 2026 0

A novel viral ORFeome proteomics platform has been unveiled, marking a monumental leap in virology by enabling the expansive analysis…

Read More
Molecular & Cell Biology

Sea Anemones Employ a Counterintuitive Viral Defense, Revealing the Diverse Evolution of Animal Immunity

Angie Faith Jul 2, 2026 0

Scientists have uncovered a previously unknown and remarkably counterintuitive method by which sea anemones defend themselves against viral infections. This…

Read More
Biotech & Genetic Research

Revolutionary Dust Surveillance System Unveiled by Ohio State Researchers for Advanced Viral Outbreak Detection in Indoor Settings

Jia Lissa May 29, 2026 0

A groundbreaking study led by researchers at The Ohio State University has introduced a novel and highly efficient method for…

Read More
Pharmaceutical R&D

Eli Lilly Acquires Engage Biologics for Up to $202 Million, Bolstering Its Genetic Medicine Pipeline with Innovative Non-Viral DNA Delivery Technology

Teuku Ryan May 21, 2026 0

Pharmaceutical giant Eli Lilly and Company has announced its agreement to acquire Engage Biologics, a California-based biotechnology firm, for a…

Read More
Pharmaceutical R&D

The Shifting Landscape of Gene Therapy: Non-Viral Approaches Emerge as Promising Alternatives

Teuku Ryan May 6, 2026 0

Cell and gene therapies (CGTs) have long been heralded for their potential to revolutionize the treatment of complex and previously…

Read More
Biotech & Genetic Research

Groundbreaking Nanodisc Platform Unveils Unprecedented Insights into Viral Protein-Antibody Interactions, Promising Accelerated Vaccine Development

Jia Lissa Apr 17, 2026 0

A pioneering scientific breakthrough has emerged from Scripps Research in California, USA, in collaboration with IAVI (New York, USA) and…

Read More
Human Brain Employs Separate Neural Pathways to Encode Content and Context for Flexible Memory FormationScience News: A Century of Empowering Public Understanding of Science, Medicine, and TechnologyThe Ascent of Collaborative AI: Fostering a New Era of Human-Machine SynergyHumanity’s Last Exam: Unpacking the Ambitious AI Benchmark Sparking Debate on General Intelligence and Safety
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ